Introduction: The aim of the current study was to investigate the outcomes of coronary reperfusion therapies
and ST-segment elevation myocardial infarction (STEMI) in patients of Eastern countries with economies in transition.
Federation, and Serbia. The overall population consisted of 23,486 consecutive patients admitted to hospitals from
January 1st to December 31st 2009. Registry data and statistics from the Organization for Economic Cooperation and
Development (OECD) countries for the same period were used for comparison (2009-2010). In-hospital mortality was
between 4% and 5% in the Western countries. In comparison mortality data were significantly larger in Serbia (10.8%)
and Bosnia and Herzegovina (11.2%), intermediate in Russian Federation (7.2%) and similar in Hungary (5.0%). The
rates of primary percutaneous coronary intervention (primary PCI) were very low in Bosnia and Herzegovina (18.3%),
low in Russian Federation (20.6%) and Serbia (22%), and high in Hungary (70%). Major risk factors for death appear
to be lack of reperfusion therapy, longer time delay from symptoms onset to hospital presentation as well as the higher
percentage of patients with clinical presentation in Killip class III/IV.
Conclusion: In-hospital STEMI case-fatality rates ranges widely in the former Eastern Bloc countries. Beyond the quality
of care provided in hospitals, differences in time delay from symptoms onset to hospital admission may strongly influence
STEMI patients’ outcome.
Keywords: Acute myocardial infarction, STEMI, mortality rate, reperfusion therapy, Serbia, Bosnia and Herzegovina, Russian
Rights & PermissionsPrintExport